Isis Pharmaceuticals'

Clinical Trials

Current Advances

New LIgand-Conjugated Antisense (LICA) Technology Broadens the Application of Isis’ Antisense Technology and Improves Potency of Generation 2.0 and 2.5 Antisense Drugs

Learn More